High mannose content of mesenchymal glioblastoma correlates with hydroxyl proton transfer-weighted (HPTw) MRI as noninvasive biomarker of tumor aggressiveness.
Overview
- Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD, USA
- Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Chemical & Biomolecular Engineering, The Johns Hopkins Whiting school of Engineering, Baltimore, MD, USA
Abstract
Glioblastoma (GBM) contains mesenchymal cancer stem cells that drive tumor aggressiveness and recurrence and exhibit aberrant glycosylation during proneural-to-mesenchymal
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Code
No file of the authors' code could be read here: it is described below, and read at its source.
kennedykrieger.org/kirby-research-center/software-databases
Availability: 1 check, the latest on 28 September 2026: the link answers (HTTP 200)
- 28 September 2026: the link answers (HTTP 200)
The paper's code and data availability statement is in the Data section.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
No dataset and no data link were found in the paper.
Data, code, and materials availability
All data and code needed to evaluate and reproduce the results in the paper are present in the paper and/
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 12 MeSH terms, 9 funders, 54 references.
Cite
This paper
Ghaemi, B., Lopez-Bertoni, H., Kuddannaya, S., Sall, S., Laterra, J., Liu, G., & Bulte, J. W. M. (2026). High mannose content of mesenchymal glioblastoma correlates with hydroxyl proton transfer-weighted (HPTw) MRI as noninvasive biomarker of tumor aggressiveness. Science advances, 12(20), eadz5324. https://
BibTeX
@article{ghaemi2026high,
author = {Ghaemi, Behnaz and Lopez-Bertoni, Hernando and Kuddannaya, Shreyas and Sall, Sophie and Laterra, John and Liu, Guanshu and Bulte, Jeff W M},
title = {{High mannose content of mesenchymal glioblastoma correlates with hydroxyl proton transfer-weighted (HPTw) MRI as noninvasive biomarker of tumor aggressiveness}},
journal = {Science advances},
year = {2026},
month = may,
volume = {12},
number = {20},
pages = {eadz5324},
publisher = {American Association for the Advancement of Science},
issn = {2375-2548},
doi = {10.1126/
url = {https://
pmid = {42127174},
pmcid = {PMC13170648}
}
RIS
TY - JOUR
AU - Ghaemi, Behnaz
AU - Lopez-Bertoni, Hernando
AU - Kuddannaya, Shreyas
AU - Sall, Sophie
AU - Laterra, John
AU - Liu, Guanshu
AU - Bulte, Jeff W M
TI - High mannose content of mesenchymal glioblastoma correlates with hydroxyl proton transfer-weighted (HPTw) MRI as noninvasive biomarker of tumor aggressiveness
T2 - Science advances
J2 - Sci Adv
PY - 2026
DA - 2026/
VL - 12
IS - 20
SP - eadz5324
SN - 2375-2548
PB - American Association for the Advancement of Science
DO - 10.1126/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1126/
"type": "article-journal",
"title": "High mannose content of mesenchymal glioblastoma correlates with hydroxyl proton transfer-weighted (HPTw) MRI as noninvasive biomarker of tumor aggressiveness",
"container-title": "Science advances",
"author": [
{
"family": "Ghaemi",
"given": "Behnaz"
},
{
"family": "Lopez-Bertoni",
"given": "Hernando"
},
{
"family": "Kuddannaya",
"given": "Shreyas"
},
{
"family": "Sall",
"given": "Sophie"
},
{
"family": "Laterra",
"given": "John"
},
{
"family": "Liu",
"given": "Guanshu"
},
{
"family": "Bulte",
"given": "Jeff W M"
}
],
"container-title-short":
"volume": "12",
"issue": "20",
"page": "eadz5324",
"DOI": "10.1126/
"PMID": "42127174",
"PMCID": "PMC13170648",
"ISSN": "2375-2548",
"publisher": "American Association for the Advancement of Science",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
13
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.32604/or.2026.079221
- Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.Journal: Oncology researchIn common: other condition, 5 references
- [2] doi:10.1158/2767-9764.crc-25-0579 [code]
- Glioblastoma Subtypes Exhibit Distinct Migration Mechanics and Immune Responses.Journal: Cancer research communicationsIn common: other condition, 4 references
- [3] doi:10.3390/ijms27167240
- 1-Piperidine Propionic Acid Inhibits PAR2/
SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness. Journal: International journal of molecular sciencesIn common: other condition, 4 references - [4] doi:10.1039/d5dd00190k [code]
- Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models.Journal: Digital discoveryIn common: other condition, 4 references
- [5] doi:10.1038/s41467-026-76587-0 [code]
- Uncovering the signaling networks of disseminated glioblastoma cells in vivo with INSIGHT.Journal: Nature communicationsIn common: other condition, 3 references
- [6] doi:10.1038/s41586-026-10612-6 [code]
- Acquired genetic and cell-state changes in IDH-mutant glioma progression.Journal: NatureIn common: other condition, 3 references
- [7] doi:10.1038/s41467-026-74058-0
- IQGAP3 bridges matrix stiffness with glioma stem cell maintenance and radioresistance by stabilizing SOX2.Journal: Nature communicationsIn common: other condition, 3 references
- [8] doi:10.1038/s41586-026-10641-1 [code]
- Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.Journal: NatureIn common: other condition, 3 references
- [9] doi:10.3390/ijms27136068 [code]
- Loss of Neuropeptide Y Signaling Accompanies the Neural-to-Mesenchymal Transcriptional Transition in Glioblastoma: A Multi-Scale Transcriptomic Analysis.Journal: International journal of molecular sciencesIn common: other condition, 3 references
- [10] doi:10.1093/braincomms/fcag248 [code]
- Field strength-dependent sensitivity of chemical exchange saturation transfer: a methodological comparison of 3 Tesla and 7 Tesla in a clinical cohort.Journal: Brain communicationsIn common: other condition, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:73dc8bedc7fb27b7…
Add the badge to its README
The badge links the code to this page. Copy one of these into the README of the paper's code: only you decide where it goes, and nothing is changed for you.
Markdown
[.
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.